Literature DB >> 24599604

Potential roles of nucleotide-binding oligomerization domain 2 in the pathogenesis of systemic lupus erythematosus.

Jing Li1, Song Wu, Ming-Rui Wang, Ting-Ting Wang, Bai-Kun Li, Ji-Min Zhu.   

Abstract

Nucleotide-binding oligomerization domain 2 (NOD2) is one of the most prominent member of the NOD-like receptors protein family that functions as intracellular pattern recognition receptors. Numerous studies have suggested the importance of NOD2 in defensing against microbial infections, regulation of the inflammatory process. It is shown that NOD2 contributes to the pathogenesis of various autoimmune and chronic inflammatory diseases, such as Crohn's disease, rheumatoid arthritis. The aim of this study is to summarize our current understandings of NOD2 function and the role of NOD2 in systemic lupus erythematosus (SLE). The following databases were searched: Pubmed, EMBASE and Web of Science for English-language sources, using the terms "lupus," "systemic lupus erythematosus," ''SLE," "immunity," "inflammatory" and "NOD2." Emerging data evidences that NOD2 has important biological effects in autoimmunity and inflammatory and might take part in the pathogenesis of SLE. Studies exploring the relationship between NOD2 and SLE are very limited. Whether NOD2 could be a potentially valuable therapeutic target for treatment for SLE, more understanding of the mechanism of NOD2 is needed in the future in SLE.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599604     DOI: 10.1007/s00296-014-2975-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  61 in total

Review 1.  The protein Nod2: an innate receptor more complex than previously assumed.

Authors:  Aurore Lecat; Jacques Piette; Sylvie Legrand-Poels
Journal:  Biochem Pharmacol       Date:  2010-07-17       Impact factor: 5.858

Review 2.  Intracellular NOD-like receptors in host defense and disease.

Authors:  Thirumala-Devi Kanneganti; Mohamed Lamkanfi; Gabriel Núñez
Journal:  Immunity       Date:  2007-10       Impact factor: 31.745

3.  Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.

Authors:  Anna Hellquist; Tiina M Järvinen; Sari Koskenmies; Marco Zucchelli; Christina Orsmark-Pietras; Linda Berglind; Jaana Panelius; Taina Hasan; Heikki Julkunen; Mauro D'Amato; Ulpu Saarialho-Kere; Juha Kere
Journal:  J Rheumatol       Date:  2009-06-30       Impact factor: 4.666

4.  The role of inflammatory bowel disease susceptibility loci in multiple sclerosis and systemic lupus erythematosus.

Authors:  P L De Jager; R Graham; L Farwell; S Sawcer; A Richardson; T W Behrens; A Compston; D A Hafler; J Kere; T J Vyse; J D Rioux
Journal:  Genes Immun       Date:  2006-04-27       Impact factor: 2.676

Review 5.  The cytosolic pattern-recognition receptor Nod2 and inflammatory granulomatous disorders.

Authors:  Naotomo Kambe; Ryuta Nishikomori; Nobuo Kanazawa
Journal:  J Dermatol Sci       Date:  2005-08       Impact factor: 4.563

Review 6.  Therapeutic potential of SIGIRR in systemic lupus erythematosus.

Authors:  Chao Wang; Chen-Chen Feng; Hai-Feng Pan; De-Guang Wang; Dong-Qing Ye
Journal:  Rheumatol Int       Date:  2013-04-02       Impact factor: 2.631

7.  Variation in NOD2 augments Th2- and Th17 responses to myelin basic protein in multiple sclerosis.

Authors:  Chris Juul Hedegaard; Christian Enevold; Finn Sellebjerg; Klaus Bendtzen; Claus Henrik Nielsen
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

8.  T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy.

Authors:  Cristiano Alessandri; Cristiana Barbati; Davide Vacirca; Paola Piscopo; Annamaria Confaloni; Massimo Sanchez; Angela Maselli; Tania Colasanti; Fabrizio Conti; Simona Truglia; Andras Perl; Guido Valesini; Walter Malorni; Elena Ortona; Marina Pierdominici
Journal:  FASEB J       Date:  2012-07-26       Impact factor: 5.191

Review 9.  Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.

Authors:  Andras Perl
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

Review 10.  NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease.

Authors:  W Strober; T Watanabe
Journal:  Mucosal Immunol       Date:  2011-07-13       Impact factor: 7.313

View more
  4 in total

1.  Downregulation of lncRNA ITSN1-2 correlates with decreased disease risk and activity of rheumatoid arthritis (RA), and reduces RA fibroblast-like synoviocytes proliferation and inflammation via inhibiting NOD2/RIP2 signaling pathway.

Authors:  Tao Yue; Xiaolei Fan; Zhanming Zhang; Zhaoyi Liu; Mengru Guo; Fengmin Bai; Xumin Gong; Chenxin Gao; Lianbo Xiao
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 2.  NOD-like receptors in autoimmune diseases.

Authors:  Li Chen; Shi-Qi Cao; Ze-Min Lin; Shi-Jun He; Jian-Ping Zuo
Journal:  Acta Pharmacol Sin       Date:  2021-02-15       Impact factor: 6.150

Review 3.  Synergistic Activation of Toll-Like and NOD Receptors by Complementary Antigens as Facilitators of Autoimmune Disease: Review, Model and Novel Predictions.

Authors:  Robert Root-Bernstein
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 4.  Nod-like Receptors: Critical Intracellular Sensors for Host Protection and Cell Death in Microbial and Parasitic Infections.

Authors:  Abdulkareem Olarewaju Babamale; Szu-Ting Chen
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.